Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis
Marta Vuerich(Beth Israel Deaconess Medical Center), Maria Serena Longhi(Beth Israel Deaconess Medical Center), Simon C. Robson(Beth Israel Deaconess Medical Center), Vilas Patwardhan(Beth Israel Deaconess Medical Center), Luíza Abrahão Frank(Beth Israel Deaconess Medical Center), Imad Nasser(Beth Israel Deaconess Medical Center), Alan Bonder(Beth Israel Deaconess Medical Center), Samiran Mukherjee(Beth Israel Deaconess Medical Center), Eva Csizmadia(Beth Israel Deaconess Medical Center), Barbora Gromová(Comenius University Bratislava), Yun Ma(King's College London), Rasika Harshe(Beth Israel Deaconess Medical Center)
Cited by 65
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Purinergic Signaling during Inflammation
|New England Journal of Medicine|2012|703